Heart Disease News and Research

Latest Heart Disease News and Research

Study suggests whole egg consumption has benefits over egg white consumption in young, healthy adults

Researchers investigated the impacts of different egg-based diets on healthy young individuals' immune, hematologic, and metabolic clinical profiles.

30 Aug 2023

A move to cut drug prices has patients with rare diseases worried

For people with cystic fibrosis, like Sabrina Walker, Trikafta has been a life-changer.

30 Aug 2023

5 things to know about the new drug pricing negotiations

The Biden administration has picked the first 10 high-priced prescription drugs subject to federal price negotiations, taking a swipe at the powerful pharmaceutical industry.

30 Aug 2023

Can muvalaplin achieve safe and tolerable plasma concentrations adequate to reduce steady-state Lp(a) levels without modulating plasminogen activity in humans?

Researchers evaluated the tolerability, safety, pharmacodynamics, and pharmacokinetic properties of muvalaplin.

30 Aug 2023

Can AI-based voice assistants provide effective CPR advice in an emergency?

Researchers described a comparative evaluation of four different voice assistants (VAs) for their ability to provide appropriate CPR instructions.

30 Aug 2023

Two studies find link between ultra-processed food and increased risk of heart attack, stroke

Recent news stories have reported that eating ultra-processed food increases the risk of heart attack and stroke, based on results from two new research studies.

30 Aug 2023

Easy-to-implement strategy more than doubles new diagnoses of cardiovascular disease

Active screening of patients with type 2 diabetes or chronic obstructive pulmonary disease (COPD) more than doubles new diagnoses of cardiovascular disease compared with usual care, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Modern blood thinners linked to reduced risk of bleeding

Modern blood-thinning drugs (known as NOACs) reduce the risk of serious bleeding by up to 45 percent compared to the traditional drug Waran in the treatment of blood clots in the legs and lungs.

29 Aug 2023

Herbs and spices can make healthy food taste better

In response to the low-fat craze of the 1990s, many food companies removed saturated fats from their products, only to replace them with sugars to maintain their palatability.

29 Aug 2023

Stunning differences found between men and women in heart disease diagnosis, treatment and symptoms

More than a dozen medical studies from around the globe show women suffer worse outcomes when diagnosed with and treated for cardiac issues – the No. 1 killer in the world according to the Centers for Disease Control.

29 Aug 2023

Produce prescriptions linked to improved health outcomes for people at risk of cardiovascular disease

People at increased risk for cardiovascular disease who participated in produce prescription programs increased their consumption of fruits and vegetables, which was associated with improved body mass index (BMI), blood sugar and blood pressure levels, as well as a decrease in food insecurity.

29 Aug 2023

Natriuresis-guided diuretic therapy improves decongestion in acute heart failure

A pragmatic natriuresis-guided diuretic approach in patients with acute heart failure significantly increases 24-hour natriuresis without impacting all-cause mortality or heart failure rehospitalization, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

ARAMIS trial finds no benefit of anakinra in acute myocarditis

The largest randomized controlled trial of patients with acute myocarditis has found that anakinra is safe but does not reduce complications. The late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Extended P2Y12 inhibitor monotherapy reduces bleeding and ischemic events in ACS patients

Extended P2Y12 inhibitor monotherapy beyond 12 months after percutaneous coronary intervention (PCI) reduces bleeding and ischemic events in acute coronary syndrome (ACS) patients at high risk for both types of events.

29 Aug 2023

Anticoagulation after primary PCI does not prevent adverse outcomes in STEMI patients

Anticoagulation after primary percutaneous coronary intervention (PCI) does not prevent adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Early initiation of dapagliflozin in acute decompensated heart failure does not improve diuretic efficiency

Early initiation of the sodium glucose co-transporter 2 (SGLT2) inhibitor dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual care in hospitalized patients with acute decompensated heart failure (ADHF), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Trial finds no benefit of minimizing atrial pacing in patients with sinus node dysfunction

Minimizing atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

SGLT2 inhibitors do not reduce 28-day mortality in hospitalized COVID-19 patients

Sodium glucose co-transporter-2 (SGLT2) inhibitors do not lead to lower 28-day all-cause mortality compared with usual care or placebo in patients hospitalized with COVID-19, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Inorganic nitrate reduces contrast-induced nephropathy in high-risk patients

Inorganic nitrate reduces contrast-induced nephropathy (CIN), improves renal outcomes and reduces cardiac events compared to placebo in patients at risk of renal injury undergoing coronary angiography for acute coronary syndrome, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Longer duration of anticoagulation therapy benefits cancer patients with isolated distal DVT

Twelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and distal deep vein thrombosis (DVT), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Heart Disease News and Research

Latest Heart Disease News and Research

Study suggests whole egg consumption has benefits over egg white consumption in young, healthy adults

A move to cut drug prices has patients with rare diseases worried

5 things to know about the new drug pricing negotiations

Can muvalaplin achieve safe and tolerable plasma concentrations adequate to reduce steady-state Lp(a) levels without modulating plasminogen activity in humans?

Can AI-based voice assistants provide effective CPR advice in an emergency?

Two studies find link between ultra-processed food and increased risk of heart attack, stroke

Easy-to-implement strategy more than doubles new diagnoses of cardiovascular disease

Modern blood thinners linked to reduced risk of bleeding

Herbs and spices can make healthy food taste better

Stunning differences found between men and women in heart disease diagnosis, treatment and symptoms

Produce prescriptions linked to improved health outcomes for people at risk of cardiovascular disease

Natriuresis-guided diuretic therapy improves decongestion in acute heart failure

ARAMIS trial finds no benefit of anakinra in acute myocarditis

Extended P2Y12 inhibitor monotherapy reduces bleeding and ischemic events in ACS patients

Anticoagulation after primary PCI does not prevent adverse outcomes in STEMI patients

Early initiation of dapagliflozin in acute decompensated heart failure does not improve diuretic efficiency

Trial finds no benefit of minimizing atrial pacing in patients with sinus node dysfunction

SGLT2 inhibitors do not reduce 28-day mortality in hospitalized COVID-19 patients

Inorganic nitrate reduces contrast-induced nephropathy in high-risk patients

Longer duration of anticoagulation therapy benefits cancer patients with isolated distal DVT

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in